Interaction between microRNA and KRAS in Glioblastoma

Glioblastoma (GBM) characterized byits rapid progression and challenging prognosis, often featuring mutations in the Kirsten rat sarcoma virus (KRAS) gene, which is crucial for numerous cellular signaling mechanisms. Emerging research underscores a significant interaction between KRAS and microRNAs (miRNAs) in these cancers, with miRNAs playing key roles as both regulators and mediators within the KRAS signaling framework. The concept of oncogene-induced senescence (OIS) is explored as a protective mechanism against tumor development, examining how K-RAS signaling is meticulously adjusted to bypass senescence, thereby enhancing cell growth and survival. In this study, we identify certain miRNAs that directly impact KRAS through mRNA targeting or by influencing its downstream signaling cascades. In turn, pathways activated by KRAS can modify the levels of specific miRNAs, establishing a feedback loop that balances cell regulation and tumor progression. We propose a theoretical framework where these interactions are crucial for deciphering the molecular underpinnings of GBM, potentially paving the way for innovative treatment approaches that focus on the miRNA-KRAS connection. © 2025 Elsevier B.V., All rights reserved.

Авторы
Beylerli Ozal A. 1 , Musaev ÉR R. 2 , Reyes-Soto Gervith 3 , Castillo-Rangel Carlos 4 , Ramirez Manuel De Jesus Encarnacion 5 , Ilyasova Tatiana M. 6
Издательство
Bentham Science Publishers
Язык
English
Статус
Published
Год
2025
Организации
  • 1 Central Research Laboratory, Bashkir State Medical University, Ufa, Russian Federation
  • 2 Department of Oncology, Sechenov First Moscow State Medical University, Moscow, Russian Federation
  • 3 Department of Head and Neck, Instituto Nacional de Cancerologia, México, Tlalpan, Mexico
  • 4 Department of Neurosurgery, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado - ISSSTE, Mexico, Mexico
  • 5 Department of Neurosurgery, RUDN University, Moscow, Russian Federation
  • 6 Department of Internal Diseases, Bashkir State Medical University, Ufa, Russian Federation
Ключевые слова
GBM; gliomagenesis; KRAS gene; miRNA; targets; therapy
Цитировать
Поделиться

Другие записи

Avatkov V.A., Apanovich M.Yu., Borzova A.Yu., Bordachev T.V., Vinokurov V.I., Volokhov V.I., Vorobev S.V., Gumensky A.V., Иванченко В.С., Kashirina T.V., Матвеев О.В., Okunev I.Yu., Popleteeva G.A., Sapronova M.A., Свешникова Ю.В., Fenenko A.V., Feofanov K.A., Tsvetov P.Yu., Shkolyarskaya T.I., Shtol V.V. ...
Общество с ограниченной ответственностью Издательско-торговая корпорация "Дашков и К". 2018. 411 с.